Location History:
- Seattle, WA (US) (1998 - 2013)
- Emeryville, CA (US) (2014)
Company Filing History:
2 out of 3,928 
1 out of 672 
1 out of 11 Years Active: 1998-2014
Title: The Innovations of Peter Bruce Challoner
Introduction
Peter Bruce Challoner is a prominent inventor based in Seattle, WA, known for his significant contributions to medical treatments, particularly in the area of endobronchial infections. With a total of five patents to his name, Challoner's work combines innovative methodologies with practical applications in the field of respiratory medicine.
Latest Patents
Challoner's recent patents showcase his expertise and commitment to advancing healthcare solutions. His notable innovations include:
1. **Methods of Treatment of Endobronchial Infections**: This patent presents innovative methods for treating endobronchial infections by administering a dry powder aerosol composition that contains 90 to 130 mg of an aminoglycoside antibiotic. This treatment protocol is designed for one to three times a day over a first treatment period of 20 to 36 days.
2. **Methods and Unit Dose Formulations for Inhalation Administration of Aminoglycoside Antibiotics**: This invention outlines the administration of a nebulized aerosol formulation for inhalation, consisting of 60 to 200 mg/ml of an aminoglycoside antibiotic, such as tobramycin, delivered in less than 4.0 ml within a timeframe of ten minutes. It also provides unit dose devices for the effective storage and delivery of the formulations.
Career Highlights
Throughout his career, Peter Challoner has made impactful strides in the pharmaceutical industry. He has worked with notable companies such as Novartis AG and Chiron Corporation, where he developed his innovative approaches to antibiotic administration and treatment of respiratory conditions. His extensive experience and dedication have positioned him as a leader in medical innovations.
Collaborations
Challoner has collaborated with several talented individuals during his career. Noteworthy coworkers include Barbara Ann Schaeffler and Robert John Speirs, both of whom have contributed to advancing his work in the field of medical inventions. These collaborations highlight the importance of teamwork in achieving groundbreaking innovations.
Conclusion
Peter Bruce Challoner stands out as an influential inventor dedicated to improving health outcomes through innovative treatments for respiratory infections. With five patents and a strong career built on collaboration and innovation, Challoner continues to be a significant figure in the medical community. His work not only reflects his expertise but also his commitment to enhancing patient care through cutting-edge solutions.